Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLCJoao V. Alessi, Mark M. Awad, Federica Pecci et al.|Journal of Thoracic Oncology|2023Cited by 91